Ipratropium bromide monohydrate is the quaternary ammonium anticholinergic salt form of ipratropium, used mainly as an inhaled or nasal bronchodilator/secretolytic in obstructive airway disease and rhinitis. It is grouped under the following drug class(es): Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include 3-exo-Ipratropium Bromide Monohydrate and Ipratropium bromide hydrate. Its PubChem CID is 441337.
Ipratropium bromide monohydrate
| CAS No | 66985-17-9, 922491-06-3 |
|---|---|
| Molecular Formula | C20H32BrNO4 |
| Molecular Weight | 430.4 g/mol |
| Synonyms | (8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate;bromide;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ipratropium bromide monohydrate is the quaternary ammonium anticholinergic salt form of ipratropium, used mainly as an inhaled or nasal bronchodilator/secretolytic in obstructive airway disease and rhinitis.
The listed CAS number is 66985-17-9, 922491-06-3.
The listed molecular formula is C20H32BrNO4.
The listed molecular weight is 430.4 g/mol.
(8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate;bromide;hydrate.
The source lists 3-exo-Ipratropium Bromide Monohydrate and Ipratropium bromide hydrate.